Compositions, systems, and methods for treating or reducing hypoxia-ischemia induced… Grant US-11931403-B2 United States of America 19 Mar 2024
Use of an RXR agonist and taxanes in treating Her2+ cancers Grant US-11896558-B2 United States of America 13 Feb 2024
Dry powder compositions for intranasal delivery Grant US-11844859-B2 United States of America 19 Dec 2023
Autoimmune disorder treatment using RXR agonists Grant US-11793781-B2 United States of America 24 Oct 2023
Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones Grant US-11690831-B2 United States of America 04 Jul 2023
Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones Grant US-11690832-B2 United States of America 04 Jul 2023
Autoimmune disorder treatment using RXR agonists Grant US-11576881-B2 United States of America 14 Feb 2023
Autoimmune disorder treatment using RXR agonists Grant US-11547684-B2 United States of America 10 Jan 2023
Treatment of disease with esters of selective RXR agonists Grant US-11517549-B2 United States of America 06 Dec 2022
Dry powder compositions for intranasal delivery Grant US-11331270-B2 United States of America 17 May 2022
Autoimmune disorder treatment using RXR agonists Grant US-11246845-B2 United States of America 15 Feb 2022
Use of an RXR agonist in treating HER2+ cancers Grant US-11224583-B2 United States of America 18 Jan 2022
Dry powder compositions for intranasal delivery Grant US-11202757-B2 United States of America 21 Dec 2021
Autoimmune disorder treatment using RXR agonists Grant US-11166927-B2 United States of America 09 Nov 2021
Dry powder compositions for intranasal delivery Grant US-11116723-B2 United States of America 14 Sep 2021
Treatment of nervous system disorders using combinations of RXR agonists and thyroid… Grant US-11065219-B2 United States of America 20 Jul 2021
Treatment of nervous system disorders using combinations of RXR agonists and thyroid… Grant US-10980761-B2 United States of America 20 Apr 2021
Treatment of nervous system disorders using combinations of RXR agonists and thyroid… Grant US-10980760-B2 United States of America 20 Apr 2021
Treatment of nervous system disorders using combinations of RXR agonists and thyroid… Grant US-10980759-B2 United States of America 20 Apr 2021
Treatment of nervous system disorders using combinations of RXR agonists and thyroid… Grant US-10973791-B2 United States of America 13 Apr 2021
Treatment of cancer with specific RXR agonists Grant US-10973788-B2 United States of America 13 Apr 2021
Use of an RXR agonist in treating HER2+ cancers Grant US-10966950-B2 United States of America 06 Apr 2021
Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones Grant US-10946001-B2 United States of America 16 Mar 2021
Autoimmune disorder treatment using RXR agonists Grant US-10945976-B2 United States of America 16 Mar 2021
Treatment of nervous system disorders using combinations of RXR agonists and thyroid… Grant US-10857117-B2 United States of America 08 Dec 2020
Treatment of nervous system disorders using combinations of RXR agonists and thyroid… Grant US-10842764-B2 United States of America 24 Nov 2020
Treatment of muscular disorders with combinations of RXR agonists and thyroid hormones Grant US-10835507-B2 United States of America 17 Nov 2020
Treatment of nervous system disorders using combinations of RXR agonists and thyroid… Grant US-10806713-B2 United States of America 20 Oct 2020
Treatment of nervous system disorders using combinations of RXR agonists and thyroid… Grant US-10702489-B2 United States of America 07 Jul 2020
Treatment of nervous system disorders using combinations of RXR agonists and thyroid… Grant US-10695312-B2 United States of America 30 Jun 2020
Treatment of cancer with specific RXR agonists Grant US-10596133-B2 United States of America 24 Mar 2020
Treatment of nervous system disorders using combinations of RXR agonists and thyroid… Grant US-10588881-B2 United States of America 17 Mar 2020
Treatment of nervous system disorders using combinations of RXR agonists and thyroid… Grant US-10485778-B2 United States of America 26 Nov 2019